Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Bailing Biotechnology is a Chinese high-tech enterprise specializing in the research, development, and manufacturing of veterinary biological products. Based in Lanzhou, the company is closely affiliated with the Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences. Its primary focus is the production of high-quality vaccines for livestock, most notably for Foot-and-Mouth Disease (FMD) and swine-related illnesses. The company operates large-scale GMP-certified facilities and plays a critical role in China's national animal disease prevention and control programs. Their portfolio includes inactivated and live attenuated vaccines designed to protect the agricultural sector from economically devastating viral outbreaks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Bailing Biotechnology.